» Articles » PMID: 2557627

An Ochre Mutation in the Vitamin D Receptor Gene Causes Hereditary 1,25-dihydroxyvitamin D3-resistant Rickets in Three Families

Overview
Specialty Science
Date 1989 Dec 1
PMID 2557627
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Hereditary 1,25-dihydroxyvitamin D3-resistant rickets is a rare autosomal-recessive disease resulting from target-organ resistance to the action of the active hormonal form of vitamin D. Four affected children from three related families with the classical syndrome of hereditary 1,25-dihydroxyvitamin D3-resistant rickets and the absence of detectable binding to the vitamin D receptor (VDR) in cultured fibroblasts or lymphoblasts were examined for genetic abnormalities in the VDR gene. Genomic DNA from Epstein-Barr virus-transformed lymphoblasts of eight family members was isolated and amplified by polymerase chain reaction techniques. Amplified fragments containing the eight structural exons encoding the VDR protein were sequenced. The DNA from all affected children exhibited a single C----A base substitution within exon 7 at nucleotide 970 that resulted in the conversion of the normal codon for tyrosine (TAC) into a premature termination codon (TAA) at amino acid 292. This mutation causes a truncation of the VDR protein thereby deleting a large portion of the steroid hormone binding domain (amino acids 292-424). Although the affected children were all homozygotic for the mutation, the four parents tested all exhibited both wild-type and mutant alleles, indicating a heterozygous state. The functional consequences of this mutation were confirmed after expression of the recreated mutant VDR cDNA in mammalian cells. Recreated mutant receptor exhibited no specific 1,25-[3H]dihydroxyvitamin D3 binding and failed to activate a cotransfected VDR promoter-reporter gene construct. Thus these findings identify an ochre mutation in a human steroid hormone receptor in patients with hereditary 1,25-dihydroxyvitamin D3-resistant rickets.

Citing Articles

Clinical characteristics and long-term management for patients with vitamin D-dependent rickets type II: a retrospective study at a single center in Saudi Arabia.

Alsagheir A, Al-Ashwal A, Binladen A, Alhuthil R, Joueidi F, Ramzan K Front Endocrinol (Lausanne). 2024; 15:1365714.

PMID: 38872968 PMC: 11169865. DOI: 10.3389/fendo.2024.1365714.


Biology and Mechanisms of Action of the Vitamin D Hormone.

Pike J, Christakos S Endocrinol Metab Clin North Am. 2017; 46(4):815-843.

PMID: 29080638 PMC: 5762112. DOI: 10.1016/j.ecl.2017.07.001.


Functional analyses of a novel missense and other mutations of the vitamin D receptor in association with alopecia.

Tamura M, Ishizawa M, Isojima T, Ozen S, Oka A, Makishima M Sci Rep. 2017; 7(1):5102.

PMID: 28698609 PMC: 5505967. DOI: 10.1038/s41598-017-05081-x.


The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights.

Pike J, Meyer M, Lee S, Onal M, Benkusky N J Clin Invest. 2017; 127(4):1146-1154.

PMID: 28240603 PMC: 5373853. DOI: 10.1172/JCI88887.


Vitamin D receptor mutations in patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets.

J Malloy P, Tasic V, Taha D, Tutunculer F, Ying G, Yin L Mol Genet Metab. 2013; 111(1):33-40.

PMID: 24246681 PMC: 3933290. DOI: 10.1016/j.ymgme.2013.10.014.


References
1.
Feldman D, Chen T, CONE C, Hirst M, Shani S, Benderli A . Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3. J Clin Endocrinol Metab. 1982; 55(5):1020-2. DOI: 10.1210/jcem-55-5-1020. View

2.
Sicinski P, Geng Y, Barnard E, Darlison M, Barnard P . The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science. 1989; 244(4912):1578-80. DOI: 10.1126/science.2662404. View

3.
Clemens T, Adams J, Horiuchi N, Gilchrest B, Cho H, Tsuchiya Y . Interaction of 1,25-dihydroxyvitamin-D3 with keratinocytes and fibroblasts from skin of normal subjects and a subject with vitamin-D-dependent rickets, type II: a model for study of the mode of action of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab. 1983; 56(4):824-30. DOI: 10.1210/jcem-56-4-824. View

4.
Chrousos G, Vingerhoeds A, Loriaux D, LIPSETT M . Primary cortisol resistance: a family study. J Clin Endocrinol Metab. 1983; 56(6):1243-5. DOI: 10.1210/jcem-56-6-1243. View

5.
Chrousos G, Loriaux D, Brandon D, Tomita M, Vingerhoeds A, Merriam G . Primary cortisol resistance: a familial syndrome and an animal model. J Steroid Biochem. 1983; 19(1B):567-75. DOI: 10.1016/0022-4731(83)90219-4. View